Govindan Rajamohan, PhD, CSIR-Institute of Microbial Technology (CSIR-IMTECH), India
BMC Medical Genomics is calling for submissions to our Collection on Genomic characterization of novel resistance mechanisms. This Collection aims to highlight research focused on the genomic characterization of novel resistance mechanisms in bacteria, viruses, fungi, and parasites.
Govindan Rajamohan, PhD, CSIR-Institute of Microbial Technology (CSIR-IMTECH), India
Govindan Rajamohan is a Chief Scientist at the CSIR- Institute of Microbial Technology, Chandigarh, India. His broad area of expertise is antimicrobial resistance (AMR) and signaling pathways, regulating the biology of critical priority pathogens, for the development of novel therapeutics utilizing multipronged approaches. His current research focuses on epidemiology & transmission of AMR and the key innate, adaptive and acquired resistance determinants that counteract stress and environmental assails in healthcare associated pathogens. He has an academic background in biotechnology and molecular microbiology.
BMC Medical Genomics is calling for submissions to our Collection on Genomic characterization of novel resistance mechanisms.
Resistance mechanisms in pathogens pose a significant challenge to effective treatment and disease management. These mechanisms, utilized by a variety of pathogens including bacteria, viruses, fungi, and parasites, lead to resistance against various therapeutic interventions. A deeper understanding and characterization of resistance mechanisms enables more effective medical interventions. It also opens avenues for research into novel intervention options as well as strategies to prevent the development of resistances by more effective utilization of interventions.
The application of genomic technologies has significantly contributed to developing new solutions for tackling resistant pathogens in medicine. By enhancing our ability to identify specific genetic mutations and investigate pathogen-host interactions, these tools have enabled researchers to gain deeper insights into the mechanisms of resistance. This ongoing advancement holds great promise for future targeted therapies.
This Collection aims to highlight research focused on the genomic characterization of novel resistance mechanisms. We invite submissions that explore the integration of genomic data into resistance studies, and the implications for public health and treatment strategies.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Image credit: © NANOCLUSTERING/SCIENCE PHOTO LIBRARY/ Science Photo Library/Gettyimages
There are currently no articles in this collection.
This Collection welcomes submission of original Research Articles, Database, Software, Case Report, Study protocol, Matters Arising and Comment. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Genomic characterization of novel resistance mechanisms" from the dropdown menu.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.